After PEG modification, it can not only bind tightly with albumin, cover the hydrolysis site of DPP-4 enzyme, but also reduce renal excretion, prolong the biological half-life and achieve the effect of long circulation

The development of these medications is interesting work as the field advances Most people would like to avoid side effects We facilitate access to the most advanced breakthroughs in the world that are published in the scientific literature to be safer for reversion of catabolism without the repeated dosing of medication For those that want medication with more convenient 1x every 3 month dosing, with significantly minimized or eliminated side-effects supported by published ISS International Space Station testing in orbit, accomplishing blood serum steady state, and avoiding the blood serum spikes of injections, and pills, and guided by our ex Pfizer vice president BJ Bormann, technology seeded by Herb Kelleher, founder of Southwest Airlines, and funded over $4 million by the DOD, is a breakthrough medicine agnostic delivery nanotechnology with 22 patents that is replacing an older $4.5 billion unicorn biotech that was funded $140 million by the Bill & Melinda Gates Foundation DM meeting A great read, thank you for sharing See more comments To view or add a comment, sign in More Relevant Posts Patent review on Drug Solubility This fascinating review covers the recent period of 20152024 and deals with various strategies companies used to tackle issues with solubility and bioavailability

You cannot flush semaglutide out of your system faster than its natural elimination timeline
10.1016/j.jchromb.2023.123688